Here, our analysis confirmed the positive epidemiological association between prostate cancer and MPB at Xq12 (AR/EDA2R-locus), pointing towards a shared pathophysiological mechanism that may involve EDA2R-signalling and AR-transactivation53. This evidence concerns the gene EDA2R and prostate cancer.